Efficacy and Safety of SHR3824 as Monotherapy in Subjects With Type 2 Diabetes
Clinical trial NCT03159052 · UNKNOWN
Trial details
- NCT number
- NCT03159052
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-01
- Primary completion
- 2018-10-01
- Enrollment
- 450
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.